Roche Eyes Adjuvant HCC Setting After Phase III Tecentriq Combination Success

But Market Opportunity Limited

Hand holding a luminated liver shape
There Are Around 10,000 HCC Patients Diagnosed Each Year • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D